Successful completion of a semi-automated enzyme-free cloning method

Stefano Bonacci1, Scilla Buccato2, Domenico Maione2

  • 1GSK Vaccines, Siena, 53100, Italy. stefano.x.bonacci@gsk.com.

Related Concept Videos